CXCL8 and infection: Next, we examined whether pretreatment with ECSN6 (prophylactic) combined with post-RV-A1 infection treatment (therapeutic) is better or as good as therapeutic strategy in attenuating RV-A1-induced disruption of TER, IL-8 release and CBF attenuation.